12.01
12.01 (0.60%)
As of Nov 27, 2023
Aeglea Biotherapeutics, Inc. [AGLE]
Source:
Company Overview
We are a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare metabolic diseases with limited treatment options. We believe our expertise in enzyme science, bioengineering and rare disease drug development coupled with an approach focused on diseases with unmet medical needs enables us to develop medicines with the potential to transform the lives of patients and families with rare metabolic diseases.
Country | United States |
Headquarters | austin, texas |
Phone Number | (512) 942-2935 |
Industry | manufacturing |
CEO | Jeffrey Goldberg |
Website | aeglea.com |